Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

316.92 -1.43 (-0.45%)
Streaming Delayed Price Updated: 9:32 AM EDT, Aug 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,413
Open 317.01
Bid (Size) 315.00 (300)
Ask (Size) 319.96 (200)
Prev. Close 318.35
Today's Range 316.77 - 318.50
52wk Range 149.38 - 326.03
Shares Outstanding 139,693,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
What to Know About This Natera Insider Transaction as Shares Surge to Record Highs ↗
Moshkevich's non-discretionary sale was executed to cover tax withholding on vesting RSUs under a Rule 10b5-1 plan. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests ↗
This sale was executed under a pre-arranged Rule 10b5-1 trading plan. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+38.5%
+38.5%
1 Month
+16.1%
+16.1%
3 Month
+59.1%
+59.1%
6 Month
+50.5%
+50.5%
1 Year
+101.8%
+101.8%

More News

Read More
News headline image
Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know ↗
Via The Motley Fool
Topics Regulatory Compliance
Natera (NASDAQ:NTRA) Beats Q2 Estimates, Raises Full-Year Revenue Guidance ↗
Via Chartmill
News headline image
A Natera Insider's Shares Vested Before the Firm Reported Revenue Surged 38%. Here's How to Read It ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
A Natera Co-Founder Sold Into Record Highs. Here's What Long-Term Investors Should Know ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Stanley Druckenmiller's Portfolio Skips Megacap Tech Almost Entirely. Here's What He's Buying Instead. ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
NTRA Q2 Deep Dive: Oncology Milestones and New Product Launches Drive Growth
Via StockStory
News headline image
Natera Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
3 Growth Stocks with All-Star Potential
Via StockStory
Topics Energy
News headline image
Natera (NASDAQ:NTRA) Reports Strong Q2 CY2026, Stock Jumps 16.3%
Via StockStory
News headline image
Natera Reports Second Quarter 2026 Financial Results
From Natera, Inc.
Via Business Wire
News headline image
Here’s How Much You Would Have Made Owning Natera Stock In The Last 10 Years ↗
Via Benzinga
News headline image
Natera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
From Natera, Inc.
Via Business Wire
News headline image
Natera (NTRA) Reports Q2: Everything You Need To Know Ahead Of Earnings
Via StockStory
News headline image
Stanley Druckenmiller Put 18% of His $3.4 Billion Portfolio in This One Stock. Is Natera a Buy? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Natera to Report its Second Quarter Results on August 6, 2026
From Natera, Inc.
Via Business Wire
News headline image
1 Unpopular Stock That Deserves Some Love and 2 We Question
Via StockStory
News headline image
3 Reasons We’re Fans of Natera (NTRA)
Via StockStory
Topics Stocks
News headline image
Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study
From Natera, Inc.
Via Business Wire
News headline image
3 Market-Beating Stocks Worth Your Attention
Via StockStory
News headline image
Finalized MolDx LCD Includes Expanded Coverage for Natera’s Prospera™ Portfolio
From Natera, Inc.
Via Business Wire
News headline image
Billionaire Stanley Druckenmiller's Top Holding Isn't Nvidia. Instead, It's This Under-the-Radar Stock That Wall Street Loves. ↗
Via The Motley Fool
News headline image
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
1 Cash-Producing Stock with Exciting Potential and 2 We Brush Off
Via StockStory

Frequently Asked Questions

Is Natera, Inc. - Common Stock publicly traded?
Yes, Natera, Inc. - Common Stock is publicly traded.
What exchange does Natera, Inc. - Common Stock trade on?
Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Natera, Inc. - Common Stock?
The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
What is the current price of Natera, Inc. - Common Stock?
The current price of Natera, Inc. - Common Stock is 316.92
When was Natera, Inc. - Common Stock last traded?
The last trade of Natera, Inc. - Common Stock was at 08/11/26 09:32 AM ET
What is the market capitalization of Natera, Inc. - Common Stock?
The market capitalization of Natera, Inc. - Common Stock is 44.27B
How many shares of Natera, Inc. - Common Stock are outstanding?
Natera, Inc. - Common Stock has 44B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.